FDA Approved: SAMSCA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Samsca (tolvaptan) from Otsuka America Pharmaceutical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• Samsca (tolvaptan)

Snippet

SUPPL AP for SAMSCA (TOLVAPTAN)